The Food and Drug Administration (FDA) Advisory Committee recommended that the new drug, aducanumab, not be approved by the FDA to treat Alzheimer’s disease on November 6, 2020. All are[…]

Exploring the Use of Weighted Blankets as a Non-Pharmacologic Intervention for Home Dwelling Older Adults with Dementia We are delighted to support Melissa Harris, a PhD student at the University[…]